Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
Press ReleaseCardiawave annonce la nomination d’Olivier Pierron en tant que Directeur Général Apr 16, 2024 READ MORE
Press ReleaseCardiawave is presenting the 30-day follow-up results from its “Valvosoft® Pivotal Study” on the treatment of severe symptomatic aortic valve stenosis at the 73rd Annual Conference of the ACC – April 6–8, 2024, Atlanta (GA) Apr 5, 2024 READ MORE
Press ReleaseCardiawave présentera les résultats de suivi à 30 jours de son étude pivot « Valvosoft® Pivotal Study » pour le traitement de la sténose valvulaire aortique sévère symptomatique à la 73ème Conférence annuelle de l’ACC – 6-8 avril 2024 Apr 5, 2024 READ MORE
About UsLes fondateurs de Cardiawave lauréats du Palmarès des Inventeurs 2024 de Le Point! Mar 7, 2024 READ MORE
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
